Xenex was founded on a compelling vision to solve an urgent problem: harness the extraordinary pathogen deactivating power of Xenon light to eliminate pathogens missed during manual cleaning and assist infection control programs and their efforts to reduce environmental contamination.
It’s changing the way healthcare professionals think about and manage disinfection. Successes brought to healthcare are increasingly being adopted by leaders in hospitality, transportation and many other businesses as they confront the challenges of the COVID-19 pandemic.
Our mission is to save lives and reduce suffering by destroying the deadly microorganisms that cause infections.
Xenex is led by an accomplished team of highly-experienced clinicians and executives.
Morris Miller is a managing partner at Tectonic Ventures as well as the Chief Executive Officer at Xenex Disinfection Services. Morris co-founded and provided the initial funding for Xenex, which produces a Robot used to disinfect hospitals. Previously he co-founded Rackspace Managed Hosting (NYSE:RAX) (brought private by Apollo for $4.3 billion). Morris also founded Curtis Hill Publishing, the first company to publish Texas case law on CD-ROM, which he successfully sold to Thomson Legal Publishing. Originally from San Antonio, Morris is a graduate of the Dedman School of Law at Southern Methodist University, The University of Texas at Austin, and Phillips Exeter Academy.
Mark Stibich, PH.D
Founder, Chief Scientific Officer
Dr. Stibich is an infectious diseases epidemiologist, founder of Xenex and Chief Scientific Officer. He holds a doctoral degree from the Johns Hopkins University School of Public Health, a Masters in Health Science, also from Johns Hopkins, and a bachelor’s degree from Yale University. He has conducted research in Russia, Tajikistan, Afghanistan, South Africa, Kenya, the United States and Brazil. He is a Fellow of the Infectious Diseases Society of America. Dr. Stibich has published more than a dozen scientific papers on ultraviolet light, HAIs and infections. He holds more than 120 granted patents on infection control approaches. He is a frequent speaker in infectious diseases including TEDx conference, DENT conference, a UN conference on Epidemic Control and Royal Society of Medicine Conference on COVID-19. He has been a principal investigator on NIH research grants and was a visiting scientist at MD Anderson Cancer Center.
Paul went to school at the University of Texas at Austin. He has a BS in Mechanical Engineering and an MBA, and has worked with companies such as Schlumberger, Rackspace and Google. He started his career in the petroleum industry with Schlumberger working at International sites before joining Rackspace Hosting. He then went on to Google where he was responsible for their worldwide hardware and datacenter infrastructure. As the CFO of Xenex, Paul is responsible for Xenex' customers and Robots, from Engineering, Supply Chain, and Manufacturing all the way to Finance and Client Services.
VP of Engineering
Juan is responsible for the company’s product development from concept to commercialization. In this role he provides the engineering team mentorship and guidance while working collectively with executive leadership to develop and meet goals. Juan is an experienced leader with a deep history in medical device development. Prior to working with Xenex, Juan led an engineering team at a well-known medical device company through the development and commercialization of multiple Class II Medical Devices.
Vice President of Manufacturing & Supply Chain
Originally from the central Texas area, Rodger went to school at St. Edward’s University. Prior to joining Xenex, Rodger held many leadership positions in the medical device and call center industries. Since joining Xenex in 2014, Rodger has held multiple positions within Xenex to include: VP of Account Management, VP Manufacturing and Supply Chain and VP of Marketing. Rodger previously served as the Chief Operating Officer for a medical device company before joining Xenex. During his 14 year career in the medical device industry, he helped grow the business from 30 employees to over 2500 employees and increased revenues from $1 million to $500 million.
VP of US Healthcare Sales
Joe Monroe serves as the Vice President of US Healthcare Sales for Xenex Disinfection Services. He is a patient advocate impacting the pace of innovation by educating leaders who aspire to improve value across the healthcare industry. Preceding his contributions as the VP of US Healthcare Sales, Joe managed Xenex's relationship with the United States Government and Inside Sales Team as a Senior Director. Joe spent his early years leading business development efforts for several entrepreneurial health care ventures. He was focused on providing insights and capabilities that direct the strategic implementation of value-based innovations. Business segments included digital health, artificial intelligence, robotics, and capital equipment. Throughout these 15 years, he was a sales contributor to many IPO's and M&As. His graduate education is from Michigan State University and the University of Michigan.
VP Finance & Accounting
Peter Pixton, VP Finance & Accounting is responsible for Accounting, Contracting, Finance, HR, IT, and Sales Operations at Xenex. He has worked in a variety of leadership positions with AT&T and KCI/Acelity, including treasury, corporate finance, and operational finance. Most recently, he was a divisional CFO for Rackspace.
VP of Human Resources
Rebecca works in close collaboration with other members of the leadership team and legal counsel to develop strategic HR plans and policies addressing the ever changing world we live in. She leads recruitment strategy and employee programs that align with the company's vision and mission. Rebecca has over 20 years of Human Resources experience. Prior to joining Xenex she led HR for Materials Marketing for nearly 10 years and is a graduate of the University of North Carolina at Chapel Hill with a degree in Industrial Relations.
Built and delivered
by a World Class Team- Join us.
We’re looking for talented and motivated people that want to help us improve the health of people everywhere. Under an experienced leadership team, we offer growth opportunities, intellectual challenge and a flexible, collaborative company culture. See our current openings. Or write us and tell us about a role that should be on this list , and how you can help us.
Candida auris (C. auris) is a multi-drug resistant yeast that can cause deadly bloodstream infections and other invasive infections of the body. C. auris infect